BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,028.04% | 88.07% | 89.82% | 118.98% | 100.93% |
| Total Depreciation and Amortization | -34.89% | 150.97% | 113.90% | 70.34% | 54.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,901.13% | -21.98% | -58.24% | -107.77% | -104.02% |
| Change in Net Operating Assets | -121.76% | -487.01% | -678.54% | -690.70% | -207.86% |
| Cash from Operations | 80.28% | 85.16% | 18,602.38% | 202.61% | 167.46% |
| Capital Expenditure | -89.43% | -43.24% | 16.44% | 50.46% | 65.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -189.01% | 14.12% | -9.75% | 332.36% | 325.07% |
| Cash from Investing | -224.66% | 108.44% | 165.29% | 113.38% | 226.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -17.54% | -294.44% | -2,206.42% | -1,688.82% | -1,629.27% |
| Issuance of Common Stock | -83.78% | -99.20% | -98.76% | -98.94% | -98.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -595.29% | -974.87% | 103.01% | 188.17% | 160.83% |
| Cash from Financing | -24.25% | -275.17% | -225.07% | -186.49% | -164.04% |
| Foreign Exchange rate Adjustments | -- | -14.71% | 212.07% | 212.07% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -209.94% | 8.68% | 1,505.37% | 251.50% | 275.50% |